• Using Short Messaging Service (SMS) Technology to Improve Medication Adherence in Patients with Specialty Chronic Diseases at Avella Specialty Pharmacy

      Mathews, Kelly; Cooley, Janet; Gianninoto, Jenna; Goal, Oliver; Lok, Daniel; Wilkerson, Aaron; College of Pharmacy, The University of Arizona (The University of Arizona., 2018)
      Purpose: The purpose was to evaluate the use of the CareSpeak Text Message Service (SMS) on adherence rate, time on therapy, and patient satisfaction. Methods: This retrospective, chart review evaluated patients using the CareSpeak SMS program at Avella Specialty Pharmacy receiving medications for cancer, hepatitis C, Human Immunodeficiency Virus (HIV), and inflammatory conditions from November 1, 2016 through November, 30 2017. Patients were grouped by disease state as well as Carespeak enrollment status. Information on proportion of days covered (PDC), time on therapy, and patient satisfaction were collected. Main Results: A total of 17,890 patients were evaluated. The median PDC ratio for patients with HIV was 94.63% for the non-Carespeak group and 96.5% for patients using Carespeak (P<0.001). Median Time on Therapy in days was significantly greater in the Carespeak group compared to the non-Carespeak group for patients receiving medications for oncology (340 vs 266.5 days, P<0.001), Hepatitis C (106 vs 101, P<0.001), HIV (396 vs 389, P=0.010), and Inflammatory Conditions (162 vs 160, P<0.001). Of a total of 1,159 satisfaction survey responses collected, Carespeak SMS received A’s or B’s (on a letter grade scale of A to F) in 91% of responses for helpfulness in managing patient health and 94.5% for ease of use. Conclusions: The CareSpeak SMS program was associated with improved PDC ratios in patients with HIV as well as prolonged Time on Therapy across all disease states. The Carespeak SMS service was generally graded highly in terms of helpfulness and ease of use.